We conducted univariate and multivariate analyses of the prognosis in MDS patients, revealing that age ≥ 60 years, ferritin > 1000 ng/ml, extremely poor chromosomal karyotype, gene mutations of TP53 and RUNX1 were independent adverse prognostic factors for MDS patients. The gene discussed is TP53; the disease is myelodysplastic syndrome.